New Alzheimer Drug - Tacrine

There are a few medicines which give a little help to patients with Alzheimer's Disease

The Journal of the American Medical Association now reports a study of almost 1300 patients with Alzheimer's to determine the value of a medicine called Tacrine.

The findings show that for approximately 3 months, Tacrine reduces the deterioration in the patients' ability to think and remember.  Furthermore, the patient's overall health improved during this time.

The odds of improving when taking Tacrine compared with placebo increased by about 50%.

This may not seem like much help but to the families any improvement is worthwhile.

I'm Medical Editor, Dr. Ted Castele, with the Medical Moment.

Return to Medical Moments Page
Return to Dr. Ted's Home Page
Go to the School of Medicine's Home Page


This page is maintained by Colin M. Richmond of the Office of Information Systems and was last updated December 11, 1998.